Skip to main content
BioSyent Inc. (TSXV:RX)
Canada flag Canada · Delayed Price · Currency is CAD
15.56
-0.14 (-0.89%)
At close: Mar 9, 2026

BioSyent Revenue

BioSyent had revenue of 12.22M CAD in the quarter ending September 30, 2025, with 27.90% growth. This brings the company's revenue in the last twelve months to 42.18M, up 22.22% year-over-year. In the year 2024, BioSyent had annual revenue of 35.03M with 10.89% growth.

Revenue (ttm)
42.18M
Revenue Growth
+22.22%
P/S Ratio
4.24
Revenue / Employee
n/a
Employees
n/a
Market Cap
178.90M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202435.03M3.44M10.89%
Dec 31, 202331.59M3.67M13.12%
Dec 31, 202227.93M-693.03K-2.42%
Dec 31, 202128.62M6.29M28.15%
Dec 31, 202022.33M907.84K4.24%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Auxly Cannabis Group 146.00M
Charlotte's Web Holdings 68.58M
Ascend Wellness Holdings 718.79M
HLS Therapeutics 77.79M
Aurora Cannabis 373.12M
Organigram Global 279.99M
Grown Rogue International 30.85M
TerrAscend 417.11M
Revenue Rankings

BioSyent News

More News